Acepodia


Acepodia is using its proprietary bioconjugation technology to develop the next wave of off-the-shelf cell therapies for cancer.

Industries

Employees

11-50

Links


Org chart

Sonny Hsiao
CEO, CSO, President & Co-Founder
Collapse
Jennifer Wang
Vp, Head Of Quality
Bill Mackin
Head, Regulatory Affairs
Kuang-Yi OuYang
Director Of Accounting
Joseph S. McCracken
SVP of Business Development
Michael Kurman
Head of Clinical Development

Board & advisors



Offices